Holen Sie sich die Stockscreener-App
67.68
2.77%
-1.93
Handel nachbörslich:
67.68
Schlusskurs vom Vortag:
$69.61
Offen:
$69.3
24-Stunden-Volumen:
1.07M
Relative Volume:
0.82
Marktkapitalisierung:
$3.60B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-38.99M
KGV:
-22.59
EPS:
-2.9966
Netto-Cashflow:
$-24.94M
1W Leistung:
-1.83%
1M Leistung:
-21.73%
6M Leistung:
+50.43%
1J Leistung:
+38.01%
1-Tages-Spanne:
$67.56
$70.73
1-Wochen-Bereich:
$66.28
$70.73
52-Wochen-Spanne:
$41.50
$90.32
Soleno Therapeutics Inc Stock (SLNO) Company Profile
Firmenname
Soleno Therapeutics Inc
Sektor
Branche
Telefon
650-213-8444
Adresse
100 MARINE PARKWAY, SUITE 400, REDWOOD CITY, CA
Vergleichen Sie SLNO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SLNO
Soleno Therapeutics Inc
|
67.68 | 3.70B | 0 | -38.99M | -24.94M | -2.9966 |
|
VRTX
Vertex Pharmaceuticals Inc
|
389.08 | 99.27B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
586.96 | 62.28B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.18 | 59.14B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
707.96 | 43.34B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
300.14 | 36.72B | 3.81B | -644.79M | -669.77M | -6.24 |
Soleno Therapeutics Inc Stock (SLNO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-23 | Eingeleitet | TD Cowen | Buy |
| 2025-03-05 | Fortgesetzt | Stifel | Buy |
| 2024-12-02 | Bestätigt | Robert W. Baird | Outperform |
| 2024-12-02 | Bestätigt | Stifel | Buy |
| 2024-09-03 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-05-10 | Eingeleitet | Robert W. Baird | Outperform |
| 2024-02-05 | Eingeleitet | Piper Sandler | Overweight |
| 2024-01-23 | Eingeleitet | Stifel | Buy |
| 2023-11-21 | Fortgesetzt | Guggenheim | Buy |
| 2020-09-29 | Eingeleitet | Guggenheim | Buy |
| 2020-01-10 | Eingeleitet | Craig Hallum | Buy |
| 2019-12-23 | Eingeleitet | Oppenheimer | Outperform |
| 2018-02-13 | Bestätigt | Maxim Group | Buy |
Alle ansehen
Soleno Therapeutics Inc Aktie (SLNO) Neueste Nachrichten
Scorpion Capital says we remain short Soleno Therapeutics - MarketScreener
Bronstein, Gewirtz & Grossman, LLC Encourages Soleno Therapeutics, Inc. (SLNO) Investors to Inquire about Securities Investigation - ACCESS Newswire
Soleno Therapeutics to Participate in Upcoming September Conferences - GlobeNewswire
Rare Disease Biotech Soleno Therapeutics Lines Up 5 Major Wall Street Healthcare Conference Presentations - Stock Titan
Soleno Therapeutics Inc.’s volatility index tracking explainedJuly 2025 Big Picture & Step-by-Step Swing Trade Plans - Newser
Is Soleno Therapeutics Inc. forming a bottoming baseJuly 2025 Pullbacks & Weekly High Potential Stock Alerts - Newser
Analyzing Soleno Therapeutics Inc. with risk reward ratio chartsCPI Data & Low Volatility Stock Recommendations - Newser
Soleno Therapeutics Meets 80-Plus Relative Strength Rating Benchmark - inkl
Regression analysis insights on Soleno Therapeutics Inc. performance2025 AllTime Highs & Technical Analysis for Trade Confirmation - Newser
Soleno Therapeutics Inc. stock trend forecast2025 Trading Volume Trends & Real-Time Buy Signal Notifications - Newser
Soleno Therapeutics (SLNO) Drops Amid Critical Scorpion Report -- Hagens Berman - GlobeNewswire
SOLENO ALERT: Bragar Eagel & Squire, P.C. is Investigating - GlobeNewswire
When is the best time to exit Soleno Therapeutics Inc.Portfolio Gains Report & Community Driven Trade Alerts - Newser
Can Soleno Therapeutics Inc. Escape Recent Bear Channel getLinesFromResByArray error: size == 0 - 더경남뉴스
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Soleno Therapeutics, Inc. (SLNO) And Encourages Investors to Reach Out - ACCESS Newswire
Will breakout in Soleno Therapeutics Inc. lead to full recovery2025 Key Highlights & Weekly Setup with ROI Potential - Newser
Why Soleno Therapeutics Inc. stock is on top investor watchlistsMarket Rally & Daily Stock Trend Watchlist - Newser
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Soleno Therapeutics, Inc.SLNO - PR Newswire
Securities Litigation and Market Volatility: Assessing the Risks in Soleno Therapeutics (SLNO) - AInvest
Rosen Law Firm Encourages Soleno Therapeutics, Inc. Investors to Inquire About Securities Class Action Investigation – SLNO - Business Wire
Soleno Therapeutics Inc. stock volume spike explained2025 Geopolitical Influence & Community Consensus Trade Signals - Newser
Published on: 2025-08-25 10:52:32 - newsyoung.net
Does Soleno Therapeutics Inc. have declining or rising EPSEarnings Risk Summary & Reliable Price Breakout Alerts - theviewers.co.kr
Long term hold vs stop loss in Soleno Therapeutics Inc.Weekly Trade Summary & Real-Time Buy Signal Notifications - Newser
Is Soleno Therapeutics Inc. currently under institutional pressureJuly 2025 Movers & Fast Gain Stock Trading Tips - theviewers.co.kr
Published on: 2025-08-23 19:04:39 - Newser
Will Soleno Therapeutics Inc. Sustain Its Chart BreakoutJuly 2025 Snapshot & Precise Swing Trade Alerts - newsyoung.net
Analyzing drawdowns of Soleno Therapeutics Inc. with statistical toolsJuly 2025 Decliners & Verified Swing Trading Watchlists - Newser
Soleno Therapeutics Inc. stock chart pattern explainedWall Street Watch & Real-Time Chart Breakout Alerts - Newser
Can Soleno Therapeutics Inc. Escape Recent Bear ChannelJuly 2025 PreEarnings & Free Daily Entry Point Trade Alerts - beatles.ru
Sating market hunger for new Prader-Willi drugs - BioWorld MedTech
Can Soleno Therapeutics Inc. sustain its profitabilityJuly 2025 Trends & Verified Chart Pattern Signals - theviewers.co.kr
FDA Approval for its Drug Lifted Soleno Therapeutics (SLNO) Shares by 60% - MSN
Piper Sandler reiterates Overweight rating on Soleno Therapeutics stock - Investing.com
Published on: 2025-08-21 02:28:29 - Newser
Wells Fargo initiates Soleno Therapeutics stock with Overweight rating By Investing.com - Investing.com Nigeria
What machine learning models say about Soleno Therapeutics Inc.2025 Institutional Moves & Daily Stock Momentum Reports - Newser
Wells Fargo initiates Soleno Therapeutics stock with Overweight rating - Investing.com India
Soleno Therapeutics Inc. Hits Price Floor — Bounce IncomingWeekly Stock Analysis & Consistent Profit Trade Alerts - classian.co.kr
Soleno Therapeutics shares rise 1.11% premarket after Wells Fargo initiates coverage with an Overweight rating. - AInvest
Top Analysts Pick: 3 Stocks to Buy Now with Significant Upside - AInvest
Wells Fargo Initiates Soleno Therapeutics at Overweight With $123 Price Target - MarketScreener
INVESTOR ALERT: Investigation of Soleno Therapeutics, Inc. (SLNO) Announced by Holzer & Holzer, LLC - GlobeNewswire
INVESTOR ALERT: Investigation of Soleno Therapeutics, Inc. (SLNO) Announced by Holzer & Holzer, LLC - GlobeNewswire Inc.
Scorpion Capital says remain short Soleno Therapeutics - MarketScreener
Down 21.7% in 4 Weeks, Here's Why Soleno Therapeutics (SLNO) Looks Ripe for a Turnaround - Yahoo Finance
Cantor Fitzgerald reiterates Overweight rating on Soleno Therapeutics stock By Investing.com - Investing.com Australia
Cantor Fitzgerald reiterates Overweight rating on Soleno Therapeutics stock - Investing.com
Soleno Therapeutics shares rise 1.62% premarket after VYKATTM XR approval for PWS treatment. - AInvest
Baird reiterates Outperform rating on Soleno Therapeutics stock amid short report - Investing.com
Soleno Therapeutics plunges after short report from Scorpion Capital - MSN
Finanzdaten der Soleno Therapeutics Inc-Aktie (SLNO)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.98%
8.06%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):